Tilray (TLRY) stock Forecast for 2022 – 2026
Last update: October 2, 2022 (06:13)Sector: Healthcare
The share price of Tilray, Inc. (TLRY) now
What analysts predict: $15.2
52-week high/low: $13.95 / $2.65
50/200 Day Moving Average: $3.606 / $5.13
This figure corresponds to the average price over the previous 50/200 days. For Tilray stocks, the 50-day moving average is the resistance level today.
For Tilray stocks, the 200-day moving average is the resistance level today.
Are you interested in Tilray, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Tilray stock price in 2022, 2023, 2024, 2025, 2026. How much will one Tilray share be worth in 2022 - 2026?
When should I take profit in Tilray stock? When should I record a loss on Tilray stock? What are analysts' forecasts for Tilray stock? What is the future of Tilray stock?
We forecast Tilray stock performance using neural networks based on historical data on Tilray stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Tilray stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Tilray shares. This happens once a day.
Historical and forecast chart of Tilray stock
The chart below shows the historical price of Tilray stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Tilray stock price can be found in the table below.
Long-term forecasts by years.
Tilray daily forecast for a month
Tilray Daily Price Targets
Tilray Stock Forecast 10-04-2022.
Pessimistic target level: 2.84
Optimistic target level: 3.23
Tilray Stock Forecast 10-05-2022.
Pessimistic target level: 2.51
Optimistic target level: 2.87
Tilray Stock Forecast 10-06-2022.
Pessimistic target level: 2.53
Optimistic target level: 3.05
Tilray Stock Forecast 10-07-2022.
Pessimistic target level: 2.62
Optimistic target level: 2.97
Tilray Stock Forecast 10-08-2022.
Pessimistic target level: 2.38
Optimistic target level: 2.80
Tilray Stock Forecast 10-09-2022.
Pessimistic target level: 2.63
Optimistic target level: 3.03
TLRY (TLRY) Monthly Stock Prediction for 2022
Tilray forecast for this year
Tilray Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $3.19328. Pessimistic: $2.47. Optimistic: $3.96
Tilray Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $3.2316. Pessimistic: $2.64. Optimistic: $3.76
Tilray Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $3.69695. Pessimistic: $3.48. Optimistic: $4.32
Tilray (TLRY) Monthly Stock Prediction for 2023
Tilray (TLRY) Monthly Stock Prediction for 2024
Tilray (TLRY) Monthly Stock Prediction for 2025
Tilray (TLRY) Monthly Stock Prediction for 2026
Tilray information and performance
Tilray’s headquarters and main manufacturing facilities are located in Nanaimo, British Columbia, Canada. In 2018, the company completed a successful collection of medical cannabis at the company campus in Portugal.
The R&D Center in Nanaimo covers an area of 18,300 square meters. In 2018, the total number of kilogram equivalents sold more than doubled to 6,478 kilograms from 3,024 kilograms in 2017.
76% of Tilray is owned by Privateer Holdings, an American private equity firm that invests in the legal cannabis industry.
The company’s shares have seen a dizzying rise since their public offering (IPO) on NASDAQ in July 2018 at a price of $ 17 per share, with a peak price of $ 234 on September 19. However, at the end of 2018, their growth declined and as of March 29, 2019, the price was $ 65 per share.
Tilray is ranked second by market capitalization among the leading companies in the industry, after Canopy Growth (CGC). Among the main competitors of the company are also Aurora Cannabis (ACB), Cronos Group (CRON).
In its short history as a public company, Tilray has achieved a lot. In 2018, the company made a number of acquisitions and signed a number of partnerships to expand its cannabis production, marketing and research activities.
1100 MAUGHAN ROAD, NANAIMO, BC, CA
Market Capitalization: 1 605 564 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -73 961 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 6.48
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.078
Trailing PE: 6.48
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 1000
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 2.886
Enterprise Value (EV) /Revenue
EV To EBITDA: -7.36
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 590281000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.